Appendix 3B
Rule 2.7, 3.10.3, 3.10.4, 3.10.5
New issue announcement,
application for quotation of additional securities and agreement
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12,
04/03/13
Name of entity
Bauxite Resources Limited
ABN
72 119 699 982
We (the entity) give ASX the following information.
Part 1 - All issues
You must complete the relevant sections (attach sheets if there is not enough space).
1 +Class of +securities issued or to be issued
Unlisted Staff Performance Rights
2 Number of +securities issued or to be issued (if known) or maximum number which may be issued
1,090,000 Unlisted Staff Performance Rights vesting as one share for each Performance Right subject to the satisfaction of Performance Criteria.
3 Principal terms of the +securities (e.g. if options, exercise price and expiry date; if partly paid
+securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)
414,200 Staff Performance Rights subject to performance criteria prior to 30 June 2014.
348,800 Staff Performance Rights subject to performance criteria prior to 30 June 2015.
327,000 Staff Performance Rights subject to performance criteria prior to 30 June 2016.
+ See chapter 19 for defined terms.
04/03/2013 Appendix 3B Page 1
4 Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities?
If the additional +securities do not rank equally, please state:
• the date from which they do
• the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment
• the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment
Upon issue if performance criteria are achieved then the resulting ordinary shares will rank equally with existing ordinary shares
5 Issue price or consideration Nil Consideration
6 Purpose of the issue
(If issued as consideration for
the acquisition of assets, clearly
identify those assets)
Staff Performance Rights issued pursuant to the Performance Rights Plan as approved by shareholders at the AGM 14 November 2013
6a Is the entity an +eligible entity No that has obtained security holder approval under rule 7.1A?
If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i
6b The date the security holder resolution under rule 7.1A was passed
N/a
6c Number of +securities issued without security holder approval under rule 7.1
N/a
6d Number of +securities issued with security holder approval under rule 7.1A
N/a
6e Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)
N/a
6f Number of +securities issued under an exception in rule 7.2
N/a
6g If +securities issued under rule
7.1A, was issue price at least 75%
of 15 day VWAP as calculated
under rule 7.1A.3? Include the
+issue date and both values.
Include the source of the VWAP
calculation.
N/a
6h If +securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements
N/a
6i Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements
N/a
7 +Issue dates
Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A.
Cross reference: item 33 of Appendix 3B.
7 January 2014
8 Number and +class of all
+securities quoted on ASX
(including the +securities in
section 2 if applicable)
9 Number and +class of all
+securities not quoted on ASX
(including the +securities in
section 2 if applicable)
+ See chapter 19 for defined terms.
04/03/2013 Appendix 3B Page 3
10 Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)
Part 2 - Pro rata issue
11 Is security holder approval required?
N/a
N/a
12 Is the issue renounceable or non- renounceable?
N/a
13 Ratio in which the +securities will be offered
N/a
14 +Class of +securities to which the offer relates
N/a
15 +Record date to determine entitlements
N/a
16 Will holdings on different registers (or subregisters) be aggregated for calculating entitlements?
N/a
17 Policy for deciding entitlements in relation to fractions
N/a
18 Names of countries in which the entity has security holders who will not be sent new offer documents
Note: Security holders must be told how their entitlements are to be dealt with.
Cross reference: rule 7.7.
N/a
19 Closing date for receipt of acceptances or renunciations
N/a
20 Names of any underwriters N/a
21 Amount of any underwriting fee or commission
N/a
22 Names of any brokers to the issue
N/a
23 Fee or commission payable to the broker to the issue
N/a
24 Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of security holders
N/a
25 If the issue is contingent on security holders' approval, the date of the meeting
N/a
26 Date entitlement and acceptance form and offer documents will be sent to persons entitled
N/a
27 If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders
N/a
28 Date rights trading will begin (if applicable)
N/a
29 Date rights trading will end (if applicable)
N/a
30 How do security holders sell their entitlements in full through a broker?
N/a
31 How do security holders sell part of their entitlements through a broker and accept for the balance?
N/a
32 How do security holders dispose of their entitlements (except by sale through a broker)?
N/a
33 +Issue date N/a
+ See chapter 19 for defined terms.
04/03/2013 Appendix 3B Page 5
Part 3 - Quotation of securities
You need only complete this section if you are applying for quotation of securities
34 Type of +securities
(tick one)
(a) +Securities described in Part 1
(b) All other +securities
Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid,
employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities
Entities that have ticked box 34(a)
Additional securities forming a new class of securities
Tick to indicate you are providing the information or documents
35 If the +securities are +equity securities, the names of the 20 largest holders of the additional +securities, and the number and percentage of additional +securities
held by those holders
36 If the +securities are +equity securities, a distribution schedule of the additional
+securities setting out the number of holders in the categories
1 - 1,000
1,001 - 5,000
5,001 - 10,000
10,001 - 100,000
100,001 and over
37 A copy of any trust deed for the additional +securities
Entities that have ticked box 34(b)
38 Number of +securities for which
+quotation is sought
39 +Class of +securities for which quotation is sought
40 Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted
+securities?
If the additional +securities do not rank equally, please state:
• the date from which they do
• the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment
• the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment
41 Reason for request for quotation now
Example: In the case of restricted securities, end of restriction period
(if issued upon conversion of another +security, clearly identify that other +security)
42 Number and +class of all
+securities quoted on ASX
(including the +securities in clause
38)
Quotation agreement
1 +Quotation of our additional +securities is in ASX's absolute discretion. ASX
may quote the +securities on any conditions it decides.
2 We warrant the following to ASX.
• The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.
• There is no reason why those +securities should not be granted
+quotation.
• An offer of the +securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.
Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty
+ See chapter 19 for defined terms.
04/03/2013 Appendix 3B Page 7
• Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.
• If we are a trust, we warrant that no person has the right to return the
+securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.
3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.
4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before
+quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.
Sam Middlemas
Company Secretary
7 January 2014
== == == == ==